james wafer
@The_Pitch_Doctor
08 September, 03:53
A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness - PubMed
Ivermectin, a US Food and Drug Administration-approved anti-parasitic agent, was found to inhibit severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication in vitro. A randomized, double-blind, placebo-controlled trial was conducted to determine the rapidity of viral clearance and saf..
https://pubmed.ncbi.nlm.nih.gov/33278625/Notice: Undefined index: tg1tga_access in /home/admin/www/anonup.com/themes/default/apps/timeline/post.phtml on line 396
Only people mentioned by The_Pitch_Doctor in this post can reply
